Bret L. Bostwick

2.0k total citations
17 papers, 414 citations indexed

About

Bret L. Bostwick is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Bret L. Bostwick has authored 17 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Bret L. Bostwick's work include Alzheimer's disease research and treatments (3 papers), Connective tissue disorders research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Bret L. Bostwick is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Connective tissue disorders research (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). Bret L. Bostwick collaborates with scholars based in United States, Australia and United Kingdom. Bret L. Bostwick's co-authors include Barry Ganetzky, Tim Fergestad, V. Reid Sutton, Joel Charrow, Carlos A. Bacino, Paul Harmatz, Ankita Patel, John A. Phillips, Ping Fang and Ravi Savarirayan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Genetics.

In The Last Decade

Bret L. Bostwick

17 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bret L. Bostwick United States 9 225 215 43 35 35 17 414
Chupong Ittiwut Thailand 14 261 1.2× 151 0.7× 31 0.7× 50 1.4× 60 1.7× 53 496
Ardinger Hh United States 6 192 0.9× 124 0.6× 46 1.1× 37 1.1× 56 1.6× 287 402
Tawfeg Ben‐Omran Qatar 11 353 1.6× 225 1.0× 32 0.7× 43 1.2× 61 1.7× 24 584
Bean Ljh 6 180 0.8× 113 0.5× 46 1.1× 37 1.1× 56 1.6× 285 386
Adam Mp 6 180 0.8× 113 0.5× 46 1.1× 37 1.1× 56 1.6× 286 388
Bird Td United States 6 162 0.7× 90 0.4× 41 1.0× 35 1.0× 51 1.5× 244 342
Jenny E.V. Morton United Kingdom 7 360 1.6× 211 1.0× 30 0.7× 71 2.0× 52 1.5× 11 574
Р. И. Хусаинова Russia 9 188 0.8× 229 1.1× 22 0.5× 24 0.7× 34 1.0× 91 485
Mefford Hc 6 163 0.7× 90 0.4× 40 0.9× 35 1.0× 51 1.5× 239 337
Geetha Anand United Kingdom 13 303 1.3× 105 0.5× 34 0.8× 58 1.7× 77 2.2× 34 565

Countries citing papers authored by Bret L. Bostwick

Since Specialization
Citations

This map shows the geographic impact of Bret L. Bostwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bret L. Bostwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bret L. Bostwick more than expected).

Fields of papers citing papers by Bret L. Bostwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bret L. Bostwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bret L. Bostwick. The network helps show where Bret L. Bostwick may publish in the future.

Co-authorship network of co-authors of Bret L. Bostwick

This figure shows the co-authorship network connecting the top 25 collaborators of Bret L. Bostwick. A scholar is included among the top collaborators of Bret L. Bostwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bret L. Bostwick. Bret L. Bostwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Farley, Jonathan E., Jeffery D. Haines, Tuyen Nguyen, et al.. (2023). An Investigational RNAi Therapeutic for Tau Lowering. Alzheimer s & Dementia. 19(S21). 1 indexed citations
2.
Cohen, Sharon, Simon Ducharme, Jared R. Brosch, et al.. (2023). Interim phase 1 part A results for ALN‐APP, the first investigational RNAi therapeutic in development for Alzheimer’s disease. Alzheimer s & Dementia. 19(S24). e082650–e082650. 8 indexed citations
3.
Haines, Jeffery D., Jonathan E. Farley, Mark K. Schlegel, et al.. (2023). RNAi knockdown of microtubule‐associated protein Tau prevents axonal damage and clears pre‐existing Tau aggregates in P301S transgenic tauopathy model mice. Alzheimer s & Dementia. 19(S21). 1 indexed citations
4.
Lacassie, Yves, Mahshid S. Azamian, Gladys Zapata, et al.. (2020). Vertical transmission of a large calvarial ossification defect due to heterozygous variants of ALX4 and TWIST1. American Journal of Medical Genetics Part A. 185(3). 916–922. 1 indexed citations
5.
Savarirayan, Ravi, M H Irving, Bret L. Bostwick, et al.. (2020). C-Type natriuretic peptide analogue therapy in children with achondroplasia. Yearbook of pediatric endocrinology. 2 indexed citations
6.
Burk, Caitlin M., Emily M. Mace, Bret L. Bostwick, et al.. (2019). Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation. The Journal of Allergy and Clinical Immunology In Practice. 8(3). 1103–1106.e3. 6 indexed citations
7.
Savarirayan, Ravi, Melita Irving, Carlos A. Bacino, et al.. (2019). C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia. New England Journal of Medicine. 381(1). 25–35. 135 indexed citations
8.
Bostwick, Bret L.. (2019). CDK13-Related Disorder. Europe PMC (PubMed Central). 1 indexed citations
9.
Karaca, Ender, Jennifer E. Posey, Bret L. Bostwick, et al.. (2019). Biallelic and De Novo Variants in DONSON Reveal a Clinical Spectrum of Cell Cycle‐opathies with Microcephaly, Dwarfism and Skeletal Abnormalities. American Journal of Medical Genetics Part A. 179(10). 2056–2066. 14 indexed citations
10.
McCarthy, John, Philip J. Lupo, Bret L. Bostwick, et al.. (2018). Schaaf‐Yang syndrome overview: Report of 78 individuals. American Journal of Medical Genetics Part A. 176(12). 2564–2574. 64 indexed citations
11.
Chinn, Iván K. & Bret L. Bostwick. (2018). The role of genomic approaches in diagnosis and management of primary immunodeficiency. Current Opinion in Pediatrics. 30(6). 791–797. 3 indexed citations
12.
Petersen, Andrea, Haley Streff, Mari Tokita, & Bret L. Bostwick. (2018). The first reported case of an inherited pathogenic CHD2 variant in a clinically affected mother and daughter. American Journal of Medical Genetics Part A. 176(7). 1667–1669. 16 indexed citations
13.
Bostwick, Bret L., Ping Fang, Ankita Patel, & V. Reid Sutton. (2016). Phenotypic and molecular characterization of focal dermal hypoplasia in 18 individuals. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 172(1). 9–20. 28 indexed citations
14.
Miller, Marcus J., Bret L. Bostwick, Adam D. Kennedy, et al.. (2016). Chronic Oral l-Carnitine Supplementation Drives Marked Plasma TMAO Elevations in Patients with Organic Acidemias Despite Dietary Meat Restrictions. JIMD Reports. 30. 39–44. 41 indexed citations
15.
Zuleger, Cindy, Michael D. Macklin, Bret L. Bostwick, et al.. (2010). In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells. Journal of Immunological Methods. 365(1-2). 76–86. 4 indexed citations
16.
Fergestad, Tim, Bret L. Bostwick, Ashleigh E. Schaffer, et al.. (2010). A Drosophila behavioral mutant, down and out ( dao ), is defective in an essential regulator of Erg potassium channels. Proceedings of the National Academy of Sciences. 107(12). 5617–5621. 10 indexed citations
17.
Fergestad, Tim, Bret L. Bostwick, & Barry Ganetzky. (2006). Metabolic Disruption in Drosophila Bang-Sensitive Seizure Mutants. Genetics. 173(3). 1357–1364. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chupong Ittiwut Breakdown of academic impact, for papers by Ardinger Hh Breakdown of academic impact, for papers by Tawfeg Ben‐Omran Breakdown of academic impact, for papers by Bean Ljh Breakdown of academic impact, for papers by Adam Mp Breakdown of academic impact, for papers by Bird Td Breakdown of academic impact, for papers by Jenny E.V. Morton Breakdown of academic impact, for papers by Р. И. Хусаинова Breakdown of academic impact, for papers by Mefford Hc Breakdown of academic impact, for papers by Geetha Anand
Rankless by CCL
2026